米国FDA、一次治療のHER2陽性胃食道腺がん（GEA）に対するBeOne MedicinesのTEVIMBRAを優先審査の対象に指定
businesswire.com
⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in